Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Patients With Primary Hyperoxaluria [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on the Phase 1/2 study of Oxabact (OC5) for Primary Hyperoxaluria assessing efficacy and safety; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperoxaluria

Drugs mentioned

• Oxabact

Snippet

Sponsor: OxThera | Conditions: Primary Hyperoxaluria | Phase 1, Phase 2 | Status: COMPLETED